Shunichiro Taniguchi
Corporate Officer/Principal bij Shinshu University
Profiel
Shunichiro Taniguchi is the founder of Anaeropharma Science, Inc. which was founded in 2004.
He held the title of Director from 2010 to 2013.
Currently, he is a Professor at Shinshu University.
Previously, he was a Professor at Kyushu University.
Dr. Taniguchi received his undergraduate and doctorate degrees from Kyushu University.
Actieve functies van Shunichiro Taniguchi
| Bedrijven | Functie | Begin |
|---|---|---|
| Shinshu University | Corporate Officer/Principal | - |
Eerdere bekende functies van Shunichiro Taniguchi
| Bedrijven | Functie | Einde |
|---|---|---|
| Kyushu University | Corporate Officer/Principal | - |
Anaeropharma Science, Inc.
 Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Founder | - |
Opleiding van Shunichiro Taniguchi
| Kyushu University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Anaeropharma Science, Inc.
Anaeropharma Science, Inc. BiotechnologyHealth Technology Anaeropharma Science, Inc. operates as a holding company that engages in the research and development of therapeutics to target hypoxic environment in solid cancers. It develops bifidobacterium technologies to create anti-cancer drugs. The firm's bifidobacterium therapeutics accumulates to the solid tumor when intravenously injected. The company was founded by Minoru Fujimori and Shunichiro Taniguchi on August 9, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
